SCHEMBL9215775

SCHEMBL9215775

CCCCCCCNC(=O)c1oc2ccc(C)cc2c1-c1ccccc1Cl

nearest known ligand 0.45

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 4/20 0.45
RAB9A P51151 4/20 0.45
HDAC1 Q13547 2/20 0.44
HDAC2 Q92769 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
HPGD P15428 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
NAAA Q02083 2/20 0.42
PTGS2 P35354 1/20 0.40
CNR1 P21554 2/20 0.39
CNR2 P34972 2/20 0.39
MAPT P10636 1/20 0.39
TP53 P04637 1/20 0.39
HDAC6 Q9UBN7 1/20 0.39
ASAH1 Q13510 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9218992 0.89 HDAC1 (0.50) NPC1RAB9AHDAC1HDAC2L3MBTL1
SCHEMBL9220337 0.85 L3MBTL1 (0.49) NPC1RAB9AHDAC1HDAC2L3MBTL1
SCHEMBL9430499 0.84 TP53 (0.50) NPC1RAB9AL3MBTL1TDP1CNR1
SCHEMBL9213682 0.84 TP53 (0.50) NPC1RAB9AL3MBTL1TDP1CNR1
SCHEMBL9219544 0.84 TP53 (0.50) NPC1RAB9AL3MBTL1TDP1CNR1
SCHEMBL9212386 0.83 L3MBTL1 (0.52) NPC1RAB9AHDAC1HDAC2L3MBTL1
SCHEMBL9431631 0.83 L3MBTL1 (0.52) NPC1RAB9AHDAC1HDAC2L3MBTL1
SCHEMBL9215785 0.83 L3MBTL1 (0.44) NPC1RAB9AHDAC1HDAC2L3MBTL1
SCHEMBL9218047 0.82 TP53 (0.51) NPC1RAB9AL3MBTL1TDP1CNR1
SCHEMBL9430225 0.82 NPC1 (0.50) NPC1RAB9AHDAC1HDAC2L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0512570-B1 Urea derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same FUJISAWA PHARMACEUTICAL CO (JP) 1995-10-11 EP disclosed
EP-0512570-A1 Urea derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1992-11-11 EP disclosed